Connect with us

Published

on

Amazon Web Services logo at the Web Summit in Lisbon.

Henrique Casinhas | Sopa Images | Lightrocket | Getty Images

Just as the periodic table is foundational to chemistry and the Human Genome Project revolutionized modern genetics, researchers at the Allen Institute for Brain Science have teamed up with Amazon Web Services to create what could become a “transformative” new resource for the field of neuroscience. 

AWS on Wednesday announced its technology will support the Allen Institute as it builds a map of the human brain, called the Brain Knowledge Platform. This platform, the first of its kind, is designed to be a complete reference of individual cells in the brain, and should eventually serve as the world’s largest open source brain cell database. 

To build the new platform, the Allen Institute is using single cell genomics technologies. Researchers measure the genes used by individual brain cells to create a “cell fingerprint,” and cells with similar fingerprints will be grouped into “cell types,” resulting in a high-resolution map of the entire brain. 

Once the reference is complete, scientists should better understand links between genetics and different cognitive functions. Researchers believe the platform could provide insights into why diseases like Alzheimer’s and Parkinson’s occur. 

“This really is like the periodic table for the brain,” Dr. Ed Lein, senior investigator at the Allen Institute for Brain Science, said Wednesday during a presentation about the platform in Washington, D.C. “It’s revealed in dramatically higher complexity than we’ve ever had access to before.”

The Allen Institute is a nonprofit research institute based in Seattle, Washington. It’s made up of a number of different institutes, including one that focuses on neuroscience, and is perhaps best known for creating a number of different large-scale data resources.  

But even though the Allen Institute is no stranger to data, there are hundreds of billions of cells in the brain — so creating a reference like the Brain Knowledge Platform means researchers will have to contend with massive amounts of data. 

“We’re just running into these enormous, enormous problems of data size,” Lein said during a briefing with reporters Wednesday. “The scale of data just keeps getting bigger and bigger.”

As such, the Allen Institute is leveraging AWS’ cloud computing and machine learning to standardize and consolidate complex brain data into one place. 

When carrying out research involving genetics and imaging, scientists are often working with petabytes and even exabytes of data. Dr. Rowland Illing, director of international public sector health at AWS, said at the briefing that consuming 40 petabytes of data would require someone to watch 4k video for 24 hours a day, seven days a week, for 100 years. 

The amount of data available to researchers is expected to keep growing in coming years, but Lein said there is also a lot of existing brain data in the neuroscience field. The problem, he said, is that much of it is disorganized and decentralized, which makes it difficult for researchers to access. 

The Allen Institute plans to use AWS’ technology to successfully interpret this disparate data even if it’s stored across different formats and locations, which Lein said will hopefully further democratize access to knowledge and bring parts of the neuroscience community together. 

“While this is really in its early phases now, the goal of the Brain Knowledge Platform is to transform this fragmented landscape of neuroscience information into a unified ecosystem,” he said.

The Allen Institute will work to build the Brain Knowledge Platform over the next five years. Lein said it is still in its early phases, but the potential for the tech is immense. 

“If we can do this, imagine the impact on the field,” he said. “We can unify the disparate parts of the field that can’t talk to one another at the moment. We can accelerate our understanding of brain function, as well as new approaches for treating diseases.”

Continue Reading

Technology

Google agrees to pay Texas $1.4 billion data privacy settlement

Published

on

By

Google agrees to pay Texas .4 billion data privacy settlement

A Google corporate logo hangs above the entrance to the company’s office at St. John’s Terminal in New York City on March 11, 2025.

Gary Hershorn | Corbis News | Getty Images

Google agreed to pay nearly $1.4 billion to the state of Texas to settle allegations of violating the data privacy rights of state residents, Texas Attorney General Ken Paxton said Friday.

Paxton sued Google in 2022 for allegedly unlawfully tracking and collecting the private data of users.

The attorney general said the settlement, which covers allegations in two separate lawsuits against the search engine and app giant, dwarfed all past settlements by other states with Google for similar data privacy violations.

Google’s settlement comes nearly 10 months after Paxton obtained a $1.4 billion settlement for Texas from Meta, the parent company of Facebook and Instagram, to resolve claims of unauthorized use of biometric data by users of those popular social media platforms.

“In Texas, Big Tech is not above the law,” Paxton said in a statement on Friday.

“For years, Google secretly tracked people’s movements, private searches, and even their voiceprints and facial geometry through their products and services. I fought back and won,” said Paxton.

“This $1.375 billion settlement is a major win for Texans’ privacy and tells companies that they will pay for abusing our trust.”

Google spokesman Jose Castaneda said the company did not admit any wrongdoing or liability in the settlement, which involves allegations related to the Chrome browser’s incognito setting, disclosures related to location history on the Google Maps app, and biometric claims related to Google Photo.

Castaneda said Google does not have to make any changes to products in connection with the settlement and that all of the policy changes that the company made in connection with the allegations were previously announced or implemented.

“This settles a raft of old claims, many of which have already been resolved elsewhere, concerning product policies we have long since changed,” Castaneda said.

“We are pleased to put them behind us, and we will continue to build robust privacy controls into our services.”

Continue Reading

Technology

Virtual chronic care company Omada Health files for IPO

Published

on

By

Virtual chronic care company Omada Health files for IPO

Omada Health smart devices in use.

Courtesy: Omada Health

Virtual care company Omada Health filed for an IPO on Friday, the latest digital health company that’s signaled its intent to hit the public markets despite a turbulent economy.

Founded in 2012, Omada offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension. The company describes its approach as a “between-visit care model” that is complementary to the broader health-care ecosystem, according to its prospectus.

Revenue increased 57% in the first quarter to $55 million, up from $35.1 million during the same period last year, the filing said. The San Francisco-based company generated $169.8 million in revenue during 2024, up 38% from $122.8 million the previous year.

Omada’s net loss narrowed to $9.4 million during its first quarter from $19 million during the same period last year. It reported a net loss of $47.1 million in 2024, compared to a $67.5 million net loss during 2023.

The IPO market has been largely dormant across the tech sector for the past three years, and within digital health, it’s been almost completely dead. After President Donald Trump announced a sweeping tariff policy that plunged U.S. markets into turmoil last month, taking a company public is an even riskier endeavor. Online lender Klarna delayed its long-anticipated IPO, as did ticket marketplace StubHub.

But Omada Health isn’t the first digital health company to file for its public market debut this year. Virtual physical therapy startup Hinge Health filed its prospectus in March, and provided an update with its first-quarter earnings on Monday, a signal to investors that it’s looking to forge ahead.

Omada contracts with employers, and the company said it works with more than 2,000 customers and supports 679,000 members as of March 31. More than 156 million Americans suffer from at least one chronic condition, so there is a significant market opportunity, according to the company’s filing.

In 2022, Omada announced a $192 million funding round that pushed its valuation above $1 billion. U.S. Venture Partners, Andreessen Horowitz and Fidelity’s FMR LLC are the largest outside shareholders in the company, each owning between 9% and 10% of the stock.

“To our prospective shareholders, thank you for learning more about Omada. I invite you join our journey,” Omada co-founder and CEO Sean Duffy said in the filing. “In front of us is a unique chance to build a promising and successful business while truly changing lives.”

WATCH: The IPO market is likely to pick up near Labor Day, says FirstMark’s Rick Heitzmann

The IPO market is likely to pick up near Labor Day, says FirstMark's Rick Heitzmann

Continue Reading

Technology

Google would need to shift up to 2,000 employees for antitrust remedies, search head says

Published

on

By

Google would need to shift up to 2,000 employees for antitrust remedies, search head says

Liz Reid, vice president, search, Google speaks during an event in New Delhi on December 19, 2022.

Sajjad Hussain | AFP | Getty Images

Testimony in Google‘s antitrust search remedies trial that wrapped hearings Friday shows how the company is calculating possible changes proposed by the Department of Justice.

Google head of search Liz Reid testified in court Tuesday that the company would need to divert between 1,000 and 2,000 employees, roughly 20% of Google’s search organization, to carry out some of the proposed remedies, a source with knowledge of the proceedings confirmed.

The testimony comes during the final days of the remedies trial, which will determine what penalties should be taken against Google after a judge last year ruled the company has held an illegal monopoly in its core market of internet search.

The DOJ, which filed the original antitrust suit and proposed remedies, asked the judge to force Google to share its data used for generating search results, such as click data. It also asked for the company to remove the use of “compelled syndication,” which refers to the practice of making certain deals with companies to ensure its search engine remains the default choice in browsers and smartphones. 

Read more CNBC tech news

Google pays Apple billions of dollars per year to be the default search engine on iPhones. It’s lucrative for Apple and a valuable way for Google to get more search volume and users.

Apple’s SVP of Services Eddy Cue testified Wednesday that Apple chooses to feature Google because it’s “the best search engine.”

The DOJ also proposed the company divest its Chrome browser but that was not included in Reid’s initial calculation, the source confirmed.

Reid on Tuesday said Google’s proprietary “Knowledge Graph” database, which it uses to surface search results, contains more than 500 billion facts, according to the source, and that Google has invested more than $20 billion in engineering costs and content acquisition over more than a decade.

“People ask Google questions they wouldn’t ask anyone else,” she said, according to the source.

Reid echoed Google’s argument that sharing its data would create privacy risks, the source confirmed.

Closing arguments for the search remedies trial will take place May 29th and 30th, followed by the judge’s decision expected in August.

The company faces a separate remedies trial for its advertising tech business, which is scheduled to begin Sept. 22.

Continue Reading

Trending